Biotech Values

[DewDiligence]

CSL Behring’s prothrombin complex works for warfarin reversal:

http://finance.yahoo.com/news/csl-behring-data-shows-4-160000981.html

Data presented today by CSL Behring at the 2012 Thrombosis and Hemostasis Summit of North America showed that a balanced, human 4-factor prothrombin complex concentrate (PCC) is as effective as the current standard of treatment in stopping bleeding in patients receiving vitamin K antagonist therapy (i.e., warfarin). Currently in the United States, fresh frozen plasma is the standard treatment for warfarin reversal.

…CSL Behring's investigational PCC contains four important pro-coagulant factors in significant quantities: Factor II (prothrombin), Factor VII, Factor IX and Factor X, as well as anticoagulant Proteins C and S.